Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 62

Sort by

Sort Order Select

Journal Articles

Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation

Blood (2022) 140 (20): 2154–2169.

https://doi.org/10.1182/blood.2021015350

Published: 2022

Includes: Multimedia, Supplemental data

Journal Articles

Mitochondrial Transfer to Host Cells from Ex Vivo Expanded Donor Hematopoietic Stem Cells

Hiroki Kawano, Yuko Kawano, Matthew J. McArthur, Laura M. Calvi, Satoshi Gojo, Scott W. Ballinger, Charles O. Smith, Roman A. Eliseev, Mark W. LaMere, Michael W. Becker

Blood (2022) 140 (Supplement 1): 4695–4696.

https://doi.org/10.1182/blood-2022-163318

Published: 2022

Journal Articles

MPL mutations in essential thrombocythemia uncover a common path of activation with eltrombopag dependent on W491

Gabriel Levy, Serge Carillo, Benjamin Papoular, Bruno Cassinat, Jean-Marc Zini, Emilie Leroy, Leila N. Varghese, Ilyas Chachoua, Jean-Philippe Defour, Steven O. Smith, Stefan N. Constantinescu

Blood (2020) 135 (12): 948–953.

https://doi.org/10.1182/blood.2019003240

Published: 2020

Includes: Supplemental data

Journal Articles

Abnormalities Of 12p Are Associated With High-Risk Acute Myeloid Leukemia: A Children’s Oncology Group Report

Betsy Hirsch, PhD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Samir Kahwash, MD, Amy Heerema-McKenney, Richard Aplenc, MD, PhD, Lillian Sung, MD, PhD, Laura Winter, PharmD, Kathleen Glick, CCRP, Stella M. Davies, MBBS, PhD, Patti Byron, MSN, RN, Robert S. Lavey, MD, Franklin O. Smith, MD, Phoenix A. Ho, MD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD, Susana C. Raimondi, PhD

Blood (2013) 122 (21): 612.

https://doi.org/10.1182/blood.V122.21.612.612

Published: 2013

Journal Articles

Gemtuzumab Ozogamicin (GO) In Children With De Novo Acute Myeloid Leukemia (AML) Improves Event-Free Survival (EFS) By Reducing Relapse Risk – Results From The Randomized Phase III Children’s Oncology Group (COG) Trial, AAML0531

Alan S. Gamis, MD, MPH, Richard Aplenc, MD, PhD, Todd A. Alonzo, PhD, Lillian Sung, MD, PhD, Soheil Meshinchi, MD, PhD, Robert B. Gerbing, MA, Susana C. Raimondi, PhD, Betsy Hirsch, PhD, Samir Kahwash, MD, Amy Heerema-McKenney, MD, Laura Winter, PharmD, Kathleen Glick, CCRP, Stella M. Davies, MBBS, PhD, Patti Byron, MSN, RN, Franklin O. Smith, MD

Blood (2013) 122 (21): 355.

https://doi.org/10.1182/blood.V122.21.355.355

Published: 2013

Journal Articles

Controlling Thrombopoietin Receptor Dimerization, Orientation and Activation Via Tryptophan 515

Jean-Philippe Defour, BPharm, Miki Itaya, MSc., Vitalina Gryshkova, PhD, Ian Brett, MSc., Christian Pecquet, PhD, Takeshi Sato, PhD, Steven O. Smith, PhD, Stefan N. Constantinescu, MD, PhD

Blood (2012) 120 (21): 3449.

https://doi.org/10.1182/blood.V120.21.3449.3449

Published: 2012

Journal Articles

Outcome of Transplantation for Acute Leukemia in Down Syndrome

Blood (2012) 120 (21): 1991.

https://doi.org/10.1182/blood.V120.21.1991.1991

Published: 2012

Journal Articles

A Phase 2 Study of Bortezomib Combined with Reinduction Chemotherapy in Children and Young Adults with Recurrent, Refractory or Secondary Acute Myeloid Leukemia: A Children's Oncology Group (COG) Study

Terzah M. Horton, MD, PhD, John Perentesis, MD, Alan S. Gamis, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, M.A., Jennifer Ballard, CRA, Kathleen Adlard, RN, Dianna Howard, MD, Franklin O. Smith, MD, Jeffrey A. Moscow, MD

Blood (2012) 120 (21): 3580.

https://doi.org/10.1182/blood.V120.21.3580.3580

Published: 2012

Journal Articles

Elevated Expression of miR-181a and miR-155 Identify Pediatric AML Patients at High Risk of Induction Failure, A Report from Children's Oncology Group.

Blood (2012) 120 (21): 2388.

https://doi.org/10.1182/blood.V120.21.2388.2388

Published: 2012

Journal Articles

Cryptic NUP98/NSD1 Translocations Are Highly Prevalent in FLT3/ITD-Positive Acute Myeloid Leukemia and Lead to High Rate of Induction Failure. Report From Children's Oncology Group

Fabiana Ostronoff, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, M.A., Michael R. Loken, PhD, Laura Pardo, Richard Aplenc, MD, PhD, Lillian Sung, MD, PhD, Susana C. Raimondi, Betsy A. Hirsch, PhD, Samir Kahwash, MD, Amy Heerema-McKenney, MD, Laura Winter, PharmD, Kathleen Glick, CCRP, Patti Byron, MSN, RN, Robert S. Lavey, MD, Stella M. Davies, MBBS, PhD, Franklin O. Smith, MD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2012) 120 (21): 529.

https://doi.org/10.1182/blood.V120.21.529.529

Published: 2012

Journal Articles

Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8 + T cells

Lucy J. Walker, Yu-Hoi Kang, Matthew O. Smith, Hannah Tharmalingham, Narayan Ramamurthy, Vicki M. Fleming, Natasha Sahgal, Alistair Leslie, Ye Oo, Alessandra Geremia, Thomas J. Scriba, Willem A. Hanekom, Georg M. Lauer, Olivier Lantz, David H. Adams, Fiona Powrie, Eleanor Barnes, Paul Klenerman

Blood (2012) 119 (2): 422–433.

https://doi.org/10.1182/blood-2011-05-353789

Published: 2012

Includes: Supplemental data

Journal Articles

Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971

Alan S. Gamis, Todd A. Alonzo, Robert B. Gerbing, Joanne M. Hilden, April D. Sorrell, Mukta Sharma, Thomas W. Loew, Robert J. Arceci, Dorothy Barnard, John Doyle, Gita Massey, John Perentesis, Yaddanapudi Ravindranath, Jeffrey Taub, Franklin O. Smith

Blood (2011) 118 (26): 6752–6759.

https://doi.org/10.1182/blood-2011-04-350017

Published: 2011

Includes: Supplemental data

Journal Articles

Multidimensional Flow Cytometry Significantly Improves Upon the Morphologic Assessment of Post-Induction Marrow Remission Status – Comparison of Morphology and Multidimensional Flow Cytometry; A Report From the Children's Oncology Group AML Protocol AAML0531

Michael R. Loken, PhD, Todd A. Alonzo, PhD, Laura Pardo, Robert B. Gerbing, M.A., Richard Aplenc, MD, MSCE, Lillian Sung, MD, PhD, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Samir Kahwash, MD, Amy Heerema-McKenney, MD, Laura Winter, PharmD, Kathleen Glick, CCRP, Patti Byron, MSN, RN, Laura Fransisco, Tanya Wallas, MS, Stella M. Davies, MBBS, PhD, Franklin O. Smith, MD, Alan S. Gamis, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2011) 118 (21): 939.

https://doi.org/10.1182/blood.V118.21.939.939

Published: 2011

Journal Articles

Presence of Residual Disease Detected by Multidimensional Flow Cytometry Identifies Patients with AML At High Risk of Relapse – a Report From the Children's Oncology Group,

Blood (2011) 118 (21): 3545.

https://doi.org/10.1182/blood.V118.21.3545.3545

Published: 2011

Journal Articles

Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/ MLL -rearranged AML patients: results of an international study

Blood (2011) 117 (26): 7102–7111.

https://doi.org/10.1182/blood-2010-12-328302

Published: 2011

Includes: Supplemental data

Journal Articles

Clinical Impact of Additional Cytogenetic Aberrations and Complex Karyotype In Pediatric 11q23/ MLL -Rearranged AML: Results from an International Retrospective Study

Blood (2010) 116 (21): 762.

https://doi.org/10.1182/blood.V116.21.762.762

Published: 2010

Journal Articles

Remission Rates In Childhood Acute Myeloid Leukemia (AML) Utilizing a Dose-Intensive Induction Regimen with or without Gemtuzumab Ozogamicin (GO): Initial Results From the Children's Oncology Group Phase III Trial, AAML0531

Alan S Gamis, MD, MPH, Todd A Alonzo, PhD, Robert B Gerbing, MS, Richard Aplenc, MD, Lillian Sung, MD, PhD, Soheil Meshinchi, MD, PhD, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Samir Kahwash, MD, Amy Heerema-McKenney, MD, Laura Winter, PharmD, Kathleen Glick, CCRP, Patti Byron, RN, Laura Burden, Tanya Wallas, Stella M. Davies, MBBS, PhD, Franklin O. Smith, MD

Blood (2010) 116 (21): 182.

https://doi.org/10.1182/blood.V116.21.182.182

Published: 2010

Journal Articles

Severe Toxicities During Pediatric Acute Myeloid Leukemia Chemotherapy: A Report From the Children's Oncology Group.

Lillian Sung, MD, PhD, Richard Aplenc, MD, MSCE, Todd A. Alonzo, PhD, Robert B. Gerbing, MS, Soheil Meshinchi, MD, PhD, Laura Burden, CCRP, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Samir Kahwash, MD, Amy Heerema-McKenney, MD, Laura Winter, PharmD, Kathleen Glick, BA, CCRP, Patti Byron, MSN, RN, Tanya Wallas, MS, Franklin O. Smith, MD, Alan S. Gamis, MD, MPH

Blood (2010) 116 (21): 1071.

https://doi.org/10.1182/blood.V116.21.1071.1071

Published: 2010

Journal Articles

High Mortality In Extreme Hyperleukocytosis In Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group.

Lillian Sung, MD, PhD, Todd A. Alonzo, PhD, Robert B. Gerbing, MS, Richard Aplenc, MD, MSCE, Soheil Meshinchi, MD, PhD, Laura Burden, CCRP, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Samir Kahwash, MD, Amy Heerema-McKenney, MD, Laura Winter, PharmD, Kathleen Glick, BA, CCRP, Patti Byron, MSN, RN, Tanya Wallas, MS, Franklin O. Smith, MD, Alan S. Gamis, MD, MPH

Blood (2010) 116 (21): 1072.

https://doi.org/10.1182/blood.V116.21.1072.1072

Published: 2010

Journal Articles

Flow Cytometric Assessment of Post Induction Response In Patients with Sub-Optimal Morphologic Response to Induction Chemotherapy- A Report From the Children's Oncology Group AML Protocol AAML0531

Michael R. Loken, PhD, Todd A. Alonzo, PhD, Laura Pardo, Robert B. Gerbing, MA, Richard Aplenc, MD, Lillian Sung, MD, PhD, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, Samir Kahwash, MD, Amy Heerema-McKenney, MD, Laura Winter, PharmD, Kathleen Glick, CCRP, Patti Byron, MSN, RN, Laura Burden, CCRP, Tanya Wallas, Stella M. Davies, MBBS, PhD, Franklin O. Smith, MD, Soheil Meshinchi, MD, PhD, Alan S. Gamis, MD, MPH

Blood (2010) 116 (21): 2740.

https://doi.org/10.1182/blood.V116.21.2740.2740

Published: 2010

NARROW

Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation

Mitochondrial Transfer to Host Cells from Ex Vivo Expanded Donor Hematopoietic Stem Cells

MPL mutations in essential thrombocythemia uncover a common path of activation with eltrombopag dependent on W491

Abnormalities Of 12p Are Associated With High-Risk Acute Myeloid Leukemia: A Children’s Oncology Group Report

Gemtuzumab Ozogamicin (GO) In Children With De Novo Acute Myeloid Leukemia (AML) Improves Event-Free Survival (EFS) By Reducing Relapse Risk – Results From The Randomized Phase III Children’s Oncology Group (COG) Trial, AAML0531

Controlling Thrombopoietin Receptor Dimerization, Orientation and Activation Via Tryptophan 515

Outcome of Transplantation for Acute Leukemia in Down Syndrome

A Phase 2 Study of Bortezomib Combined with Reinduction Chemotherapy in Children and Young Adults with Recurrent, Refractory or Secondary Acute Myeloid Leukemia: A Children's Oncology Group (COG) Study

Elevated Expression of miR-181a and miR-155 Identify Pediatric AML Patients at High Risk of Induction Failure, A Report from Children's Oncology Group.

Cryptic NUP98/NSD1 Translocations Are Highly Prevalent in FLT3/ITD-Positive Acute Myeloid Leukemia and Lead to High Rate of Induction Failure. Report From Children's Oncology Group

Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8 + T cells

Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971

Multidimensional Flow Cytometry Significantly Improves Upon the Morphologic Assessment of Post-Induction Marrow Remission Status – Comparison of Morphology and Multidimensional Flow Cytometry; A Report From the Children's Oncology Group AML Protocol AAML0531

Presence of Residual Disease Detected by Multidimensional Flow Cytometry Identifies Patients with AML At High Risk of Relapse – a Report From the Children's Oncology Group,

Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/ MLL -rearranged AML patients: results of an international study

Clinical Impact of Additional Cytogenetic Aberrations and Complex Karyotype In Pediatric 11q23/ MLL -Rearranged AML: Results from an International Retrospective Study

Remission Rates In Childhood Acute Myeloid Leukemia (AML) Utilizing a Dose-Intensive Induction Regimen with or without Gemtuzumab Ozogamicin (GO): Initial Results From the Children's Oncology Group Phase III Trial, AAML0531

Severe Toxicities During Pediatric Acute Myeloid Leukemia Chemotherapy: A Report From the Children's Oncology Group.

High Mortality In Extreme Hyperleukocytosis In Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group.

Flow Cytometric Assessment of Post Induction Response In Patients with Sub-Optimal Morphologic Response to Induction Chemotherapy- A Report From the Children's Oncology Group AML Protocol AAML0531

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only